This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glatman-Freedman, A.
Right arrow Articles by Casadevall, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glatman-Freedman, A.
Right arrow Articles by Casadevall, A.

 Previous Article  |  Next Article 

Infection and Immunity, January 2000, p. 335-341, Vol. 68, No. 1
0019-9567/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Clearance and Organ Distribution of Mycobacterium tuberculosis Lipoarabinomannan (LAM) in the Presence and Absence of LAM-Binding Immunoglobulin M

Aharona Glatman-Freedman,1,2,3,* Aron J. Mednick,4 Nikoletta Lendvai,4 and Arturo Casadevall1,4,5

Division of Infectious Diseases,1 Departments of Pediatrics,2 Internal Medicine,5 and Microbiology and Immunology,4 and Children's Hospital at Montefiore,3 Albert Einstein College of Medicine, Bronx, New York 10461

Received 5 May 1999/Returned for modification 24 June 1999/Accepted 5 October 1999

Lipoarabinomannan (LAM) is a component of the mycobacterial surface which has been associated with a variety of deleterious effects on immune system function. Despite the importance of LAM to the pathogenesis of mycobacterial infection, there is no information available on its fate in vivo. In this study, we determined the pharmacokinetics and tissue distribution of exogenously administered LAM in mice. For measurements of serum and tissue LAM concentrations, we developed an enzyme-linked immunosorbent assay which used monoclonal antibodies of different isotypes to capture and detect LAM at concentrations of >= 0.4 µg/ml. Intravenous administration of LAM to mice resulted in transient serum levels with organ deposition in the spleen and in the liver. Immunohistochemical studies localized LAM to the spleen marginal zone macrophages and, to a lesser degree, to liver macrophages. When LAM was administered to mice previously given a LAM-binding immunoglobulin M (IgM), LAM was very rapidly cleared from circulation. In those mice, deposition of LAM in the spleen was significantly reduced while LAM deposition in the liver increased. Administration of LAM-binding IgM resulted in significant levels of IgM to LAM in bile consistent with an increased hepatobiliary excretion of LAM in the presence of specific antibody. Bile, liver extracts, and bile salts were found to rapidly inactivate the immunoreactivity of LAM. The results indicate that serum clearance and organ deposition of LAM in mice are affected by the presence of LAM-binding antibody and suggest a mechanism by which antibody could modify the course of mycobacterial infection.


* Corresponding author. Mailing address: Albert Einstein College of Medicine, Golding Building, Room 702, 1300 Morris Park Ave., Bronx, NY 10461. Phone: (718) 430-3768. Fax: (718) 430-8701. E-mail: afreedma{at}aecom.yu.edu.


Infection and Immunity, January 2000, p. 335-341, Vol. 68, No. 1
0019-9567/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Lang, M. L., Glatman-Freedman, A. (2006). Do CD1-Restricted T Cells Contribute to Antibody-Mediated Immunity against Mycobacterium tuberculosis?. Infect. Immun. 74: 803-809 [Full Text]  
  • Yager, E., Bitsaktsis, C., Nandi, B., McBride, J. W., Winslow, G. (2005). Essential Role for Humoral Immunity during Ehrlichia Infection in Immunocompetent Mice. Infect. Immun. 73: 8009-8016 [Abstract] [Full Text]  
  • Lang, G. A., Illarionov, P. A., Glatman-Freedman, A., Besra, G. S., Lang, M. L. (2005). BCR targeting of biotin-{alpha}-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments. Int Immunol 17: 899-908 [Abstract] [Full Text]  
  • Glatman-Freedman, A., Casadevall, A., Dai, Z., Jacobs, W. R. Jr., Li, A., Morris, S. L., Navoa, J. A. D., Piperdi, S., Robbins, J. B., Schneerson, R., Schwebach, J. R., Shapiro, M. (2004). Antigenic Evidence of Prevalence and Diversity of Mycobacterium tuberculosis Arabinomannan. J. Clin. Microbiol. 42: 3225-3231 [Abstract] [Full Text]  
  • SANCHEZ, M. A., DIAZ, N. L., ZERPA, O., NEGRON, E., CONVIT, J., TAPIA, F. J. (2004). ORGAN-SPECIFIC IMMUNITY IN CANINE VISCERAL LEISHMANIASIS: ANALYSIS OF SYMPTOMATIC AND ASYMPTOMATIC DOGS NATURALLY INFECTED WITH LEISHMANIA CHAGASI. Am J Trop Med Hyg 70: 618-624 [Abstract] [Full Text]  
  • Navoa, J. A. D., Laal, S., Pirofski, L.-A., McLean, G. R., Dai, Z., Robbins, J. B., Schneerson, R., Casadevall, A., Glatman-Freedman, A. (2003). Specificity and Diversity of Antibodies to Mycobacterium tuberculosis Arabinomannan. CVI 10: 88-94 [Abstract] [Full Text]  
  • Schwebach, J. R., Glatman-Freedman, A., Gunther-Cummins, L., Dai, Z., Robbins, J. B., Schneerson, R., Casadevall, A. (2002). Glucan Is a Component of the Mycobacterium tuberculosis Surface That Is Expressed In Vitro and In Vivo. Infect. Immun. 70: 2566-2575 [Abstract] [Full Text]  
  • Vodovotz, Y., Shubing Liu, , McCloskey, C., Shapiro, R., Green, A., Billiar, T. R. (2001). The hepatocyte as a microbial product-responsive cell. Innate Immunity 7: 365-373 [Abstract]  
  • Schwebach, J. R., Casadevall, A., Schneerson, R., Dai, Z., Wang, X., Robbins, J. B., Glatman-Freedman, A. (2001). Expression of a Mycobacterium tuberculosis Arabinomannan Antigen In Vitro and In Vivo. Infect. Immun. 69: 5671-5678 [Abstract] [Full Text]